References
- Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006;107:1645–1655.
- Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288–298.
- Lewis DR, Seibel NL, Smith AW, et al. Adolescent and young adult cancer survival. J Natl Cancer Instit Monogr. 2014;2014:228–235.
- Pulte D, Gondos A, Brenner H. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981–2005. Cancer. 2009;115:4973–4979.
- Bleyer A, Choi M, Fuller CD, et al. Relative lack of conditional survival improvement in young adults with cancer. Semin Oncol. 2009;36:460–467.
- Keegan TH, Grogan RH, Parsons HM, et al. Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California. Thyroid. 2015;25:635–648.
- Wolfson J, Sun CL, Kang T, et al. Impact of treatment site in adolescents and young adults with central nervous system tumors. J Natl Cancer Instit. 2014;106:dju166.
- Go RS, Bartley AC, Al-Kali A, et al. Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults. Leukemia. 2016; 30:1177–1180.
- Martin S, Ulrich C, Munsell M, et al. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007;12:816–824.
- Patel MI, Ma Y, Mitchell BS, et al. Understanding disparities in leukemia: a national study. Cancer Causes Control. 2012;23:1831–1837.
- Patel MI, Ma Y, Mitchell BS, et al. Age and genetics: how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia? Am J Clin Oncol. 2015;38:159–164.
- Mitchell JM, Meehan KR, Kong J, et al. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol. 1997;15:2644–2651.
- Patel MI, Ma Y, Mitchell B, et al. How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia?. Cancer Epidemiol Biomark Prevent. 2015;24:344–349.
- Baker KS, Davies SM, Majhail NS, et al. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15:1543–1554.
- Sekeres MA, Peterson B, Dodge RK, et al. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia. Blood. 2004;103:4036–4042.
- Pulte D, Redaniel MT, Jansen L, et al. Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups. Haematologica. 2013;98:222–229.
- Patel MI, Schupp CW, Gomez SL, et al. How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox. J Clin Oncol. 2013;31:3572–3578.
- Markides KS, Coreil J. The health of Hispanics in the southwestern United States: an epidemiologic paradox. Public Health Rep. (Washington, DC: 1974). 1986;101:253–265.
- Ruiz JM, Steffen P, Smith TB. Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health. 2013;103:e52–e60.
- Bradley CJ, Dahman B, Jin Y, et al. Acute myeloid leukemia: how the uninsured fare. Cancer. 2011;117:4772–4778.